# Hyperlipoproteinemia A as a Marker of Cardiovascular Risk in Patients With Stage 4 Chronic Kidney Disease

> **NCT07141628** · — · NOT_YET_RECRUITING · sponsor: **Centre Hospitalier Universitaire de Nīmes** · enrollment: 300 (estimated)

## Conditions studied

- CKD
- Cardiovascular Diseases

## Interventions

- **DIAGNOSTIC_TEST:** lipoprotein A level dosing

## Key facts

- **NCT ID:** NCT07141628
- **Lead sponsor:** Centre Hospitalier Universitaire de Nīmes
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07141628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07141628, "Hyperlipoproteinemia A as a Marker of Cardiovascular Risk in Patients With Stage 4 Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07141628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*